Immediate Impact

58 standout
Sub-graph 1 of 24

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Metal-catalysed C–H bond activation and borylation
2022 Standout
2 intermediate papers

Works of Steven Bai being referenced

Design, structure–activity relationship, and pharmacokinetic profile of pyrazole-based indoline factor Xa inhibitors
2007
Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor
2003

Author Peers

Author Last Decade Papers Cites
Steven Bai 73 41 32 82 58 6 242
Jakal Amin 8 18 4 53 98 7 223
P J Murphy 106 60 2 37 4 8 274
A. F. L. Van Der Spek 29 29 80 29 14 261
M. Forsman 29 49 9 24 6 8 167
Hassan A. El-Sayad 27 115 223 24 5 293
Pengcai Shi 107 66 139 3 9 289
Ko‐Chin Khoo 23 16 109 3 11 288
Andrew J. Brunk 19 147 2 48 3 7 241
J. P. Currie 23 61 2 84 7 12 268
Emily Nazarian 20 41 39 78 5 223

All Works

Loading papers...

Rankless by CCL
2026